Theragnostics inks AstraZeneca agreement

AuntMinnie.com staff writers
Sep 4, 2019

Molecular radiotherapy developer Theragnostics said it has signed an intellectual property agreement with AstraZeneca.

The agreement allows Theragnostics to develop radiotherapy based on radionuclide-labeled poly (ADP-ribose) polymerase (PARP) inhibitors, a class of oncology drugs that block the PARP enzyme, which cancer cells use in response to DNA damage.
Latest in Radiation Oncology/Therapy
Sun Nuclear Corporation logo displayed on a large white banner at an indoor trade show or conference booth
Sun Nuclear launches Simon platform for linac QA
November 4, 2026
Female healthcare worker in blue scrubs smiling with arms crossed, standing with medical team colleagues in background
PA enacts licensure law for imaging, radiation therapy professionals
October 29, 2026
ASTRO cancer care facility sign with blue letters and pink planter with white and yellow flowers
ASTRO updates prostate cancer treatment guideline
October 28, 2026
Mirion Technologies corporate logo and text displayed on white trade show booth signage
Mirion donates to IAEA’s Rays of Hope initiative
October 21, 2026
Related Stories
2021 09 14 23 49 7847 Business Handshake 400
Molecular Imaging
Theragnostics enters licensing deal with AAA for Ga-68 PET
2020 07 28 23 23 5650 Business Hands Cooperation 400
Molecular Imaging
Theragnostics names two new board directors
2017 09 14 23 05 1167 Cancer Cell 400
Molecular Imaging
Theragnostics, German hospital to study THG-008 for PET
2018 08 28 18 59 9066 Artificial Intelligence Ai 400
AI
AstraZeneca, Qure.ai partner for lung cancer diagnosis
More in Radiation Oncology/Therapy
Sun Nuclear launches Simon platform for linac QA
By AuntMinnie.com staff writers
Simon works with the company’s SunCheck QA software or on its own.
November 4, 2026
Sun Nuclear Corporation logo displayed on a large white banner at an indoor trade show or conference booth
PA enacts licensure law for imaging, radiation therapy professionals
By AuntMinnie.com staff writers
Imaging technologist societies are lauding the signing of a bill that requires imaging professionals to obtain licensure.
October 29, 2026
Female healthcare worker in blue scrubs smiling with arms crossed, standing with medical team colleagues in background
ASTRO updates prostate cancer treatment guideline
By AuntMinnie.com staff writers
The update includes a strong recommendation for five-session stereotactic body radiation therapy (SBRT) as a standard option for many patients.
October 28, 2026
ASTRO cancer care facility sign with blue letters and pink planter with white and yellow flowers
Mirion donates to IAEA’s Rays of Hope initiative
By AuntMinnie.com staff writers
The donations will support an IAEA Anchor Centre in sub-Saharan Africa.
October 21, 2026
Mirion Technologies corporate logo and text displayed on white trade show booth signage
PSMA-PET scans guide LDR brachytherapy in prostate cancer
By Will Morton
At last follow-up, 79% of patients were without evidence of disease.
October 5, 2026
X-ray scan of pelvis with prostate gland highlighted in red, medical diagnostic imaging
ASTRO: Shorter SBRT regimens improve patient physical function
By Amerigo Allegretto
Patients who underwent five treatments of SBRT for pancreatic cancer had better physical function and experienced less fatigue.
September 30, 2026
ASTRO cancer care facility entrance sign with blue letters and pink base decorated with white and yellow flowers
ASTRO: Radiosurgery may extend survival for SCLC with brain metastases
By Erik L. Ridley
Patients receiving SRS lived almost 18 months after treatment.
September 29, 2026
ASTRO cancer care facility entrance sign with blue dimensional letters and purple planter with white and yellow flowers
ASTRO: Radiosurgery reduces suicidal ideation in major depressive disorder
By Will Morton
Before treatment, 14 of the 20 patients (70%) reported suicidal thoughts, while after treatment, one patient (5%) did.
September 29, 2026
Professional presenter at ASTRO conference podium delivering research presentation with laptop and display screen
GEHC, MGB team to apply generative AI for radiation therapy
By AuntMinnie.com staff writers
The expanded collaboration aims to develop more personalized radiation therapy.
September 28, 2026
GE HealthCare logo featuring purple gradient circle with company name in gray text
ASTRO: 10-year outcomes support hypofractionated radiotherapy in breast cancer
By Will Morton
While hypofractionated radiotherapy is well established for whole-breast irradiation after breast-conserving surgery, there is little long-term data on its use post-mastectomy.
September 28, 2026
Speaker presenting at ASTRO's 68th Annual Meeting plenary session with panelists seated at table
ASTRO: Few patients adhere to long-term hormone therapy after lumpectomy
By Erik L. Ridley
The results provide real-world context for treatment approaches that consider omitting radiation therapy after lumpectomy.
September 28, 2026
ASTRO cancer care facility signage with blue letters, green accents, and pink base decorated with white and yellow flowers
ASTRO: Navigator program improves access for African American breast cancer patients
By Will Morton
Afua Ofori-Darko, a medical student at Case Western Reserve, presented early phase I results of a structured patient navigation program.
September 28, 2026
Professional headshot of a woman with long reddish-brown hair in a modern office setting with large windows
Page 1 of 475
Next Page